{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:10:25Z","timestamp":1792606225528,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K16313"],"award-info":[{"award-number":["JP23K16313"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jiac.2026.102903","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:46:15Z","timestamp":1767977175000},"page":"102903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of Japan-specific cefiderocol susceptibility testing methods in multidrug-resistant gram-negative isolates from Japan and Bangladesh"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5640-5811","authenticated-orcid":false,"given":"Takashi","family":"Okanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niinyo","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Koshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadatomo","family":"Oyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1239-708X","authenticated-orcid":false,"given":"Tomonori","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kunishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3714-8100","authenticated-orcid":false,"given":"Mitsuo","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromu","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jiac.2026.102903_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","article-title":"Cefiderocol: a siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative Bacilli","volume":"79","author":"Zhanel","year":"2019","journal-title":"Drugs"},{"issue":"Suppl 7","key":"10.1016\/j.jiac.2026.102903_bib2","doi-asserted-by":"crossref","first-page":"S529","DOI":"10.1093\/cid\/ciz825","article-title":"The role of iron and siderophores in infection, and the development of siderophore antibiotics","volume":"69","author":"Page","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.102903_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jgar.2024.05.009","article-title":"In vitro activity of cefiderocol against carbapenemase-producing and meropenem-non-susceptible Gram-negative bacteria collected in the Japan antimicrobial resistant bacterial surveillance","volume":"38","author":"Kayama","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jiac.2026.102903_bib4","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2025"},{"issue":"4","key":"10.1016\/j.jiac.2026.102903_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jiac.2019.12.004","article-title":"In vitro effect of an antimicrobial combination therapy without colistin and tigecycline for CPE and non-CPE","volume":"26","author":"Okanda","year":"2020","journal-title":"J Infect Chemother"},{"issue":"4","key":"10.1016\/j.jiac.2026.102903_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijantimicag.2006.01.004","article-title":"Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp","volume":"27","author":"Woodford","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.jiac.2026.102903_bib8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.diagmicrobio.2019.03.003","article-title":"Reproducibility of broth microdilution MICs for the novel siderophore cephalosporin, cefiderocol","volume":"94","author":"Hackel","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.jiac.2026.102903_bib9","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/antibiotics12030604","article-title":"Disc diffusion and ComASP\u00ae cefiderocol microdilution panel to overcome the challenge of cefiderocol susceptibility testing in clinical laboratory routine","volume":"12","author":"Bianco","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"5","key":"10.1016\/j.jiac.2026.102903_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.01648-24","article-title":"Impact of media brand on cefiderocol disk diffusion results","volume":"63","author":"DeMarco","year":"2025","journal-title":"J Clin Microbiol"},{"issue":"20","key":"10.1016\/j.jiac.2026.102903_bib11","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.3390\/diagnostics14202318","article-title":"Issues with cefiderocol testing: comparing commercial methods to broth microdilution in iron-depleted medium","volume":"14","author":"Stracquadanio","year":"2024","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.jiac.2026.102903_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01649-20","article-title":"Cefiderocol antimicrobial susceptibility testing against multidrug-resistant gram-negative bacilli: a comparison of disk diffusion to broth microdilution","volume":"59","author":"Morris","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2026.102903_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1253160","article-title":"Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9","volume":"14","author":"Gaillot","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2026.102903_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.612020","article-title":"Characteristics of carbapenemase-producing Klebsiella pneumoniae isolated in the ICU of the largest tertiary hospital in Bangladesh","volume":"11","author":"Okanda","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jiac.2026.102903_bib15","first-page":"129","article-title":"Carbapenem-resistant Enterobacterales, pathogen surveillance, 2022","volume":"45","year":"2024","journal-title":"IASR"},{"issue":"2","key":"10.1016\/j.jiac.2026.102903_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","volume":"17","author":"Grundmann","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.jiac.2026.102903_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2026.102903_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2024.106972","article-title":"Comparison of available methods to evaluate cefiderocol susceptibility in Acinetobacter spp","volume":"223","author":"Pasteran","year":"2024","journal-title":"J Microbiol Methods"},{"issue":"1","key":"10.1016\/j.jiac.2026.102903_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00951-20","article-title":"Cefiderocol antimicrobial susceptibility testing considerations: the achilles' heel of the Trojan horse?","volume":"59","author":"Simner","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.jiac.2026.102903_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00877-21","article-title":"Contribution of PER-type and NDM-type \u03b2-Lactamases to cefiderocol resistance in Acinetobacter baumannii","volume":"65","author":"Poirel","year":"2021","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:28:24Z","timestamp":1773959304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1341321X26000012"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102903","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Japan-specific cefiderocol susceptibility testing methods in multidrug-resistant gram-negative isolates from Japan and Bangladesh","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102903"}}